Skip to main content

Table 2 Patient Characteristics (n = 89)

From: The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study

 

S

S + RT

P value

No. of Patients

62

27

 

Sex (M:F)

45:17

19:8

 

Age (years)(mean)

25-80 (57)

23-66 (53)

 

Duke stage

  

0.211

   A or B

13 (21%)

3 (11%)

 

   C

49 (79%)

24 (89%)

 

Liver mets stage

  

0.561

   I or II

28 (45%)

14 (52%)

 

   III

34 (55%)

13 (48%)

 

Pelvic surgery

   

   APR

9 (15%)

4 (15%)

 

   LAR

51 (82%)

21 (78%)

 

   Hartmann

2 (3%)

2 (7%)

 

Lateral resection margin

  

NS

   Positive

10 (16%)

3 (11%)

 

   Negative

52 (84%)

24 (89%)

 

Liver surgery

  

0.151

   Resection

22 (61%)

16 (80%)

 

   RFA

4 (11%)

2 (10%)

 

   Resection + RFA

10 (28%)

2 (10%)

 

Chemotherapy

   

   FL

3

24

 

   FOLFOX

37

2

 

   FOLFIRI

22

1

 
  1. Liver metastasis staging according to Pettavel and Morgenthaler
  2. Abbreviations: APR = abdominoperineal resection; LAR = low anterior resection; RFA = radiofrequency ablation; FL = 5-FU/leucovorin; FOLFOX = 5-FU/leucocovorin/oxaliplatin; FOLFIRI = 5-FU/leucovorin/irrinotecan.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us